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Tax et al.  have recently described a  T  cell-specific mAb (1) termed WT31; 
this reagent is mitogenic for resting T  lymphocytes in the presence of functional 
macrophages and blocks cytolysis mediated by alloantigen-specific T  cell clones 
(2, 3). Binding of WT31  is blocked by preincubation of target cells with OKT3, 
showing that both antibodies define either an identical or closely related antigenic 
determinant (1).  However, biochemical studies have suggested that WT31  may 
not  be  directed  at  the  low  molecular  mass  (25  kD  and  20  kD)  T3  proteins. 
Rather,  it  was  postulated  (3,  4)  that  the  determinant  recognized by WT31  is 
borne by a constant region of the T3-associated, 90 kD heterodimeric structure 
that functions as a specific receptor for antigen recognition (5, 6). This hypothesis 
is based upon the finding that WT31 precipitates predominantly high mol. mass 
material (90 kD under nonreducing conditions), while additional antibodies with 
apparently similar specificity, such as Leu-4, precipitate predominantly low mol. 
mass proteins (25-20 kD).  Because these differences are only relative, immuno- 
precipitations strongly suggested, but did not formally prove, that WT31  has a 
unique specificity compared with conventional anti-T3 antibodies. 
In  this  study,  we  show  that  a  number  of  cytotoxic  clones  derived  from 
circulating blood of a  human fetus aged 25 wk express T3 proteins defined by 
the well characterized DFCI  2ad2,  OKT3,  Leu-4, or UCHT1  antibodies.  Yet, 
only a  fraction of these cloned cell lines reacts with WT31  mAb.  Furthermore, 
surface expression of WT31  structure correlated with the capacity for effector 
cells  to  recognize  alloantigens,  while  NK  reactions  appeared  to  be  WT31- 
independent. 
Material and  Methods 
Human Fetal Cloned Cell Lines.  We obtained normal fetal peripheral blood by using 
novel sampling methods aimed at prenatal diagnosis (7,  8).  Blood (0.5 ml) of the fetus 
studied here was sampled by direct puncture of the cord because the mother presented a 
toxoplasmosis seroconversion; there was no biological evidence for infection of the child. 
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Fetal PBMC (FPBMC) were extracted by Ficoll-Hypaque density gradient centrifugation 
(2 x  l06 cells/ml). FPBMC were cocultured with irradiated (6,000 rad) LAZ 388 EBV- 
tvansfbrmed B lymphocytes. Responder lymphocytes were restimulated two times (day 8 
and  12). On day 19 bulk culture cells were cloned by limiting dilution at 0.66 cells/well 
and remaining cells were frozen in several aliquots. For cloning, feeder layer consisted of 
irradiated LAZ 388 cells (5,000 rad) plus irradiated allogeneic adult lymphocytes (3,000 
rad). Cultures were fed every 3 d with lymphocyte conditioned medium (LCM) containing 
If.-2, prepared as described previously (9). Culture medium was DME supplemented with 
15%  human  AB serum.  Further propagation of individual cell lines was performed by 
diluting  lymphocytes (~1000  cells/well  in  the same  type of 96  V-bottomed microtiter 
plates used for initial cloning) repeatedly on irradiated feeder layer cells and adding LCM 
every 3 d until they reached a concentration of 2 x  106 cells/ml, mAbs used to phenotype 
the clones were: Coulter clones T4 and T8; anti-T3 (DFCI 2ad2), OKT3, Leu-4, UCHT 1  ; 
WT31 (1); we also employed the "Pan NK" anti-NKH1A mAb (10). 
Phenotypic analysis  was performed on an Epics C (Coulter Electronics, Inc., Hialeah, 
FL) after indirect immunofluorescence assays,  as previously described (9).  10,000 cells 
were analyzed in  each  sample;  histograms shown  in  Fig.  1 display number of cells  vs. 
intensity fluorescence measured on a log scale.  Negative control was the irrelevant anti- 
B1 mAb used at saturating concentration. 
Cytotoxicity Assays.  Cytotoxicity assays were performed according to a standard chro- 
mium release method described previously (9).  All experiments were done in triplicate 
using V-bottomed microtiter plates. Assays  were generally performed for 3 h at 37°C 
using 5,000 target cells per well. Medium was RPMI plus 5% human AB serum. 
Cell Sorting Experiments.  To purify WT31 + cells from bulk culture lymphocytes, ceils 
were stained by indirect immunofluorescence using WT31 ascites at saturating concentra- 
tions plus  FITC-conjugated goat anti-mouse  F(ab')z  immunoglobulin  (Coulter clone). 
WT31 + and  WT31- sorted cells  were collected in  RPMI  1640 containing 5%  normal 
human  serum,  washed  twice,  and  resuspended  in  fresh  medium  for functional assays. 
Trypan blue dye exclusion was performed on both sorted populations, and viability was 
always >95%. Purity of sorted cells was >95% in each fraction (~95% WT31 + cells in the 
positive fraction, ~<5% WT31 cells in the negative fraction). 
Results and Discussion 
To study  NK active  lymphocytes as  early as  possible during  normal  human 
development, we have recently generated cytotoxic clones derived from periph- 
eral blood of one healthy fetus aged 25 wk. A  first series of clones (Ythier et al., 
manuscript  submitted  for publication)  was  obtained  after  stimu|ation  of fetal 
lymphocytes  by  an  allogeneic,  EBV-transformed  B  lymphoblastoid  cell  line 
termed  LAZ  388.  When  tested  for cytotoxic activity,  all  cloned  lymphocytes 
were found to lyse the NK susceptible target cell line K562, but none killed LAZ 
388  immunizing  cells.  Yet,  T3 proteins were expressed on these fetal effector 
cells and it was questioned whether they possess (in addition to T3) appropriate 
receptor structures to recognize alloantigens. Genes encoding Ti molecules were 
studied in one clone termed  F6C7.  Clonal rearrangements of Ti /3 genes were 
found in  F6C7  cells that  expressed corresponding messenger  RNA.  However, 
we could not detect any Tic~ transcripts, suggesting that there was no construction 
of a conventional [T3/Tia-/3] receptor on the surface of the fetal lymphocytes. 
In  light  of these  results,  further  cloning  procedures  were  performed  here 
starting from bulk cultured cells that had been frozen after three (day 0, 8, and 
12) stimulations  by  irradiated  LAZ  388  B  lymphoblastoid cells.  A  total  of  19 
clones was obtained that displayed sufficient proliferative capacity to be assayed 
at least two times for both phenotype and functional activity. They are listed in 
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TABLE  I 
Reactivity of Cloned Cells with mAbs 
Clone 
Phenotype  Cytotoxic function* 
T3  WT31  T4  T8  NKHIA  K562  LAZ  388 
F6A4  +  -  -  +  +  +++  - 
F6A5  +  -  -  +  +  +++  - 
F6A7  +  -  -  +  +*  +++  - 
F6B9  +  +  +  .... 
F6B  10  +  -  -  +  +  ++  - 
F6C7  +  -  -  +  +  +++  - 
F6D7  +  -  -  +  +  ++  - 
F6DI0  +  +  +  .... 
F6D  12  +  -  -  +  +  +++  - 
F6E6  +  +  +  .... 
F6F5  +  -  -  +  +  ++  - 
F6F7  +  -  -  +  +  ++  - 
F6F8  +  -  -  +  +  ++  - 
F6F9  +  -  -  +  +*  ++  - 
F6G3  +  +  -  +  +  +++  +++ 
F6G7  +  -  -  +  +  ++  - 
F6GIO  +  +  -  +  +*  +++  +++ 
F6H1  +  -  -  +  +  ++  - 
F6H2  +  +  -  +  +*  +++  +++ 
Reactivity was assayed by indirect immunofluorescence and subsequent cytofluorometric 
analysis. 
*  Most cells in a given clone appear to be positive, but only weak fluorescence is detected. 
*  Cytotoxicity assays were performed for 3  h  at generally 6:1  E/T  cell ratio. Results represent 
mean cytotoxicity for triplicate culture,  -  <  5%;  5%  <~  +  <  25;  25  ~<  ++  <50;  +++ 
50%.  +  ~90/cells  stained by corresponding MAb;  -  ~5  cells stained with corresponding 
antibodies, 
mAbs, as well as their ability to lyse either immunizing LAZ 388 or K562 target 
cells. 
Three colonies (F6B9, F6D 10, and F6E6) were found to be noncytotoxic and 
to express a conventional T3 +, WT31 +, T4 +, T8-,  NKH1A-  "inducer" pheno- 
type. The great majority of the clones (16 out of 19) reacted with anti-T3,  TS, 
and NKH 1A mAhs.  A  comparable phenotype has been previously described  in 
studies of adult peripheral  blood.  It is represented  by a number of clones, such 
as JT9  (9,  11),  which  are  derived  from  a  minor  population  of  circulating 
T3+NKH1A + lymphocytes  (10). JT9  cells  have been  extensively  studied;  they 
were  found  to  transcribe  both  Tio~ and  Ti/3  genes  and  to  surface  express  a 
conventional  49/43  kD  receptor  structure  termed  NKTa  (11,  12).  Moreover 
anti-NKTa mAb was shown to block non-MHC-restricted  cytotoxicity displayed 
byJT9 cells against various NK susceptible tumor cell lines.  However,  13 clones 
(represented by F6C7 cells on Fig.  1 A) described here are phenotypically distinct 
from JT9 (Fig.  1 C) because they do not express WT31, while reacting normally 
with several well characterized antibodies specific for T3 structures such as DFCI 
2ad2,  Leu-4,  OKT3,  or  UCHT1  (Fig.  1A).  This  finding  indicates  that  the 
antigenic  determinant  recognized  by  WT31  is  not  borne  by  the  20-25  kD 
proteins.  In light of previous biochemical data (3, 4) obtained with this mAb, we 
can conclude  that  WT31  recognizes  an  invariant epitope  of the human T  cell 
receptor. Moreover, because Tio~ transcripts could not be detected in F6C7 cells, 
it is reasonable to postulate that WT31  mAb is directed at either the a  chain or, 
alternatively, at an antigenic configuration whose construction depends upon the 
presence  of both  ~  and  /3  chains.  Several  studies  have  suggested  an  ordered 
expression  of y,  fl,  and finally  c~ chains during T  cell  ontogeny  (13,  14);  thus, 1604 
A 
NOWILL  ET  AL.  BRIEF  DEFINITIVE  REPORT 
UCHTI  ~  F6C7 
c 
CL 
FIGURE  1. 
F6G3 
ITS JT 
Indirect immunofluorescence  analysis of NK clones.  Saturating  concentration  of 
all mAbs used in these assays was predetermined  on appropriate antigen-bearing cells. Negative 
control  was  anti-B1  mAb.  Reactivity  of anti-B1  was  superimposable  to  that  of  WT31  and 
NKTa  on  F6C7  cells.  Histograms  presented  here display number of cells (Y) versus intensity 
of fluorescence  (X) on a logarithm  scale.  Reactivity of all reagents with cloned cells was >90% 
or <5%. 
TABLE  II 
Compared Cytotoxic Activity of WT31 + and WT31- Fractions 
Percent reac-  Target cells 
Cells used  tivity  WT-31 *  K562'  LAZ 388 
F6 unsorted cells  62  41  54 
F6 WT-31 + sorted cells  >90  25  62 
F6 WT-31- sorted ceils  -<5  42  9 
•  Determined by indirect immunofluorescent assays. 
•  E/T ratio, 15:1; 3-h assay; numbers represent mean of triplicate  cultures;  SD ~<5%. 
WT31  may represent a unique tool to easily assess the differentiation  stage of a 
given T  cell by means of simple surface analysis. 
Three additional  clones F6G3,  F6G10,  and F6H2 expressed T3,  WT31,  T8, 
and  NKH1A  antigens.  Representative  immunofluorescence  analysis  of  F6G3 
lymphocytes is presented in Fig.  1 B. These clones were found to kill immunizing 
cells, as  well as  the  NK  target  cell  line  K562,  suggesting  a  positive  correlation 
between surface expression of WT31  and the capacity to recognize alloantigens. 
If this was correct, most if not all cytotoxic activity against LAZ 388 cells should 
be found  in the  WT31 + subpopulation  of the cell line used  for cloning experi- 
ments. To address the point, bulk culture cells were separated  into WT31 ÷ and 
WT31-  fractions  (representing  respectively  62  and  38%  of  the  cells)  by  cell 
sorting.  Cytotoxic  activity  against  either  alloantigen-bearing  cells or  K562  was 
then  compared  using  unsorted  lymphocytes  vs.  WT31 +  and  WT31-  effector 
cells. Both bulk culture and WT31 + sorted lymphocytes were found to kill LAZ 
388,  as  well as  K562  cells.  In  contrast,  there  was little  if any  killing (Table  II) 
against LAZ 388 in the WT31- subpopulation  that mediated strong NK activity, 
correlating with that of T3 + WT31- clones. NOWILL  ET  AL.  BRIEF  DEFINITIVE  REPORT  1605 
These results support the view that  recognition  of MHC gene products may 
require the presence of WT31  determinant,  that  is of either  the a  chain  or of 
both c~ and ¢/chains.  In contrast, recognition of NK target structures appears to 
be WT31-independent.  Yet, a Tia/~ heterodimer (NKTa) previously identified 
on JT9 cells (11) was shown to be involved in NK-mediated lysis against K562 
and a variety of additional genetically unrelated tumor cell lines. This apparent 
discrepancy leads us to postulate that certain NK reactions are mediated through 
Ti  molecules,  but  do  not,  in  fact,  necessitate  the  construction  of a  complete 
conventional  T  cell  receptor.  Note that  a  putative  NK receptor is  likely to be 
related to T3 proteins when they are surface expressed. Indeed anti-T3  blocks 
cytotoxic function of F6C7 cells (Ythier et al.,  manuscript  submitted for publi- 
cation) and,  more generally, of all  T3 ÷ WT31- NK clones described here (not 
shown).  Further  studies will  be conducted to search  for the presence of a  T3- 
associated  (physically,  or  at  least  functionally)  molecule  on  WT31-  cells  and 
assess its possible role in NK target cell recognition. 
The  diversity  of  NK  active  lymphocytes  is  now  well  established,  whereas 
receptor structures used by most of these cytotoxic cells are not yet characterized. 
This situation has created considerable confusion. In particular,  it is not known 
whether  the  distinct  lymphocyte  subsets  (for  example:  Tll-T3-WT31-- 
N KH 1A  +, T 11 +T3-WT31 -N KH 1A  +, T 11 +T3+WT31 -NKH 1A+,and T 11 +T3 +- 
WT3 I+NKH1A  +) that  display apparently similar cytotoxic activity against con- 
ventional  target  cells such as K562 are  related  or if they evolve from  distinct 
differentiation pathways. The present experiments suggest that relevant cloning 
strategies may contribute to definitions of intermediate stages of T  cell matura- 
tion, one of them being possibly reflected here by fetal T3+WT31- lympbocytes. 
Hopefully, a  better  characterization  of these early T  cell  differentiation  steps 
will help to clarify the origin of the various "NK" lymphocyte populations. 
Summary 
We have conducted a phenotypic and functional analysis of 19 cloned cell lines 
generated after allogeneic stimulation of circulating lymphocytes from a normal 
human  fetus aged 25 wk.  Using a  limited series of mAbs (Anti-T3,  WT31, T4, 
T8, and NKH1A), cloned cells were found to fall in three groups. Three clones 
have a conventional "inducer" phenotype. Three clones have a phenotype (T3 ÷, 
WT31 +,  T8 +,  and  NKH1A  +)  similar  to  that  of certain  NK  active  mature  T 
lymphocytes present in adult peripheral  blood. In contrast,  13 cell lines display 
surface  characteristics  that  have  not  been  described  previously.  Indeed,  they 
express T3 proteins but not the WT31 determinant.  In light of previous studies, 
these results show that WT31  mAb is a unique reagent directed at an invariant 
epitope of the human  T  cell receptor that  is not present on all circulating T3 ÷ 
fetal  lymphocytes.  Functionally  the  T3 +,  WT31 +,  and  NKH1A  + clones  were 
found to kill  immunizing  LAZ  388  cells, as well as K562,  while T3 +, WT31-, 
and  NKH1A  +  clones  display  NK-like  function  exclusively.  Moreover,  only 
WT31 + lymphocytes present in the cell line used for cloning experiments have 
the capacity to recognize alloantigen-bearing  cells. Together, these data suggest 
that expression of WT31 may be necessary for recognition of alloantigens, while 
NK reactions mediated by T3 + lymphocytes are WT31-independent. 1606  NOW1LL ET  AL.  BRIEF  DEFINITIVE REPORT 
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